Rasilez HCT, single-pill combination of Rasilez and diuretic, receives Swiss approval for the treatment of high blood pressure
Links shared publicly online about this topic.
- 2,493total visits
Rasilez HCT, single-pill combination of Rasilez and diuretic, receives Swiss approval for the treatment of high blood pressure
Basel, October 29, 2008 - Rasilez HCT (aliskiren and hydrochlorothiazide), a single-pill combination of two high blood pressure medicines - first-in-class direct renin inhibitor Rasilez[*] (aliskiren) and the diuretic hydrochlorothiazide (HCT) - has been approved by Swissmedic as a new treatment for high blood pressure.
View full resource at novartis.com
Tags: Heart Disease, High Blood Pressure, High Blood Pressure Medication
Most Recently Shared on November 8, 2008 at 12:05 pm By:
Novartis.com => Rasilez HCT®, single-pill combination of Rasilez® and diuretic, receiv.. http://tinyurl.com/6gjtwn
Advertisement
